Literature DB >> 24810723

Ethics and regulatory complexities for pragmatic clinical trials.

Jeremy Sugarman1, Robert M Califf2.   

Abstract

Mesh：

Year:  2014        PMID： 24810723     DOI： 10.1001/jama.2014.4164

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  61 in total

1.  The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.

Authors:  Mary Jane Welch; Rachel Lally; Jennifer E Miller; Stephanie Pittman; Lynda Brodsky; Arthur L Caplan; Gina Uhlenbrauck; Darcy M Louzao; James H Fischer; Benjamin Wilfond
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

Review 2.  Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).

Authors:  Emily P Zeitler; Sana M Al-Khatib; Joseph P Drozda; Larry G Kessler; Ajay J Kirtane; David F Kong; John Laschinger; Danica Marinac-Dabic; Marie-Claude Morice; Terrie Reed; Art Sedrakyan; Kenneth M Stein; James Tcheng; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2015-07-30       Impact factor: 4.749

3.  The Cumulative Burden of Mental, Substance Use, and General Medical Disorders and Rehospitalization and Mortality After an Injury.

Authors:  Douglas F Zatzick; Ali Rowhani-Rahbar; Jin Wang; Joan Russo; Doyanne Darnell; Leah Ingraham; Lauren K Whiteside; Roxanne Guiney; Margot Kelly Hedrick; Frederick P Rivara
Journal:  Psychiatr Serv       Date:  2017-02-01       Impact factor: 3.084

4.  Research on medical practices and the ethics of disclosure.

Authors:  David Magnus; Benjamin S Wilfond
Journal:  Pediatrics       Date:  2015-01-12       Impact factor: 7.124

Review 5.  "Targeted" consent for pragmatic clinical trials.

Authors:  David Wendler
Journal:  J Gen Intern Med       Date:  2015-01-14       Impact factor: 5.128

6.  Toward an Information Infrastructure for Global Health Improvement.

Authors:  C P Friedman; J C Rubin; K J Sullivan
Journal:  Yearb Med Inform       Date:  2017-09-11

7.  A Proposed Process for Reliably Updating the Common Rule.

Authors:  Benjamin E Berkman; David Wendler; Haley K Sullivan; Christine Grady
Journal:  Am J Bioeth       Date:  2017-07       Impact factor: 11.229

Review 8.  Pragmatic Clinical Trials in Osteoporosis.

Authors:  Giovanni Adami; Kenneth G Saag; Maria I Danila
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

9.  Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC).

Authors:  Mark Clemons; Sasha Mazzarello; John Hilton; Anil Joy; Julie Price-Hiller; Xiaofu Zhu; Shailendra Verma; Anne Kehoe; Mohammed Fk Ibrahim; Marta Sienkiewicz; Carol Stober; Lisa Vandermeer; Brian Hutton; Ranjeeta Mallick; Dean Fergusson
Journal:  Support Care Cancer       Date:  2018-08-11       Impact factor: 3.603

10.  Understanding preferences regarding consent for pragmatic trials in acute care.

Authors:  Neal W Dickert; David Wendler; Chandan M Devireddy; Sara F Goldkind; Yi-An Ko; Candace D Speight; Scott Yh Kim
Journal:  Clin Trials       Date:  2018-10-03       Impact factor: 2.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.